Recurrent/Metastatic Endometrial Cancer
1 clinical trials · Condition
◉ Watch Recurrent/Metastatic Endometrial Cancer
| Record | Firm | Date |
|---|---|---|
| Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial (NCT06771154) | Peking Union Medical College Hospital | 2025-04-01 |
Track Recurrent/Metastatic Endometrial Cancer automatically
Every clearance here is in the API, with alerts when new ones post.